Three-Year Outcomes of VEGF Inhibitors in Naive Branch Retinal Vein Occlusion-Reference-Cited by-同舟云学术

Three-Year Outcomes of VEGF Inhibitors in Naive Branch Retinal Vein Occlusion

Published:2024-04 Issue: Volume: Page:
ISSN:2468-6530
Container-title:Ophthalmology Retina
language:en
Short-container-title:Ophthalmology Retina

Author:

Alforja Socorro,Hunt Adrian^ORCID,Nguyen Vuong,O’Toole Louise^ORCID,Gabrielle Pierre-Henry^ORCID,Invernizzi Alessandro,Mehta Hemal^ORCID,Ponsioen Theodorus Leonardus^ORCID,Squirrell David^ORCID,Casaroli-Marano Ricardo P.^ORCID,Barthelmes Daniel^ORCID,Gillies Mark C.,Zarranz-Ventura Javier^ORCID,Squirrell David,Marsh Bacchus,Jaross N.,Barry R.,Gabrielle Pierre-Henri,Creuzot-Garcher Catherine,Young S.,Carnota Pablo,Gallego-Pinazo Roberto,Gillies Mark,Hunt Adrian,Louw Z.,Sararols Laura,Berdoukas P.,Young S.,Fraser-Bell Samantha,Higueras Alejandro,Alforja Socorro,Figueras-Roca Marc,Casaroli-Marano Ricardo P.,Zarranz-Ventura Javier,Lavid Francisco Javier,Gil M Alvarez,Muñoz P Catalán,Asencio-Duran Monica,Calvo Pilar,Sanchez-Monroy Jorge,Puzo Martin,Rodriguez-Maqueda Mariano,Parrado-Carrillo Alba,Alarcon Isaac,Furness G.,Ponsioen Theodorus Leonardus,McAllister I.,Invernizzi Alessandro,Arnold Jennifer,Cass H.,O´Toole Louise,Nothling S.,Mehta Hemal,Every S.,Hinchcliffe P.,Barthelmes Daniel,Villoria Daniel Velazquez

Publisher

Elsevier BV

Reference33 articles.

1. Guidelines for the management of retinal vein occlusion by the European Society of Retina Specialists (EURETINA);Schmidt-Erfurth;Ophthalmologica,2019

2. Retinal vein occlusions Preferred Practice Pattern®;Flaxel;Ophthalmology,2020

3. Ranibizumab for macular edema following branch retinal vein occlusion: six-month primary end point results of a phase III study;Campochiaro;Ophthalmology,2010

4. Intravitreal aflibercept for macular edema following branch retinal vein occlusion: 52-week results of the VIBRANT study;Clark;Ophthalmology,2016

5. Sustained benefits from ranibizumab for macular edema following branch retinal vein occlusion: 12-month outcomes of a phase III study;Brown;Ophthalmology,2011